lilly - Search News

News

Eli Lilly Stock Dives

Eli Lilly: 50% Upside For LLY Stock?

In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.

Fast Company · 20h

Eli Lilly is giving Novo Nordisk a run for its money—so why is LLY stock still down today?

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors remain unconvinced.

MarketWatch · 17h

Health Care Down After Eli Lilly Earnings -- Health Care Roundup

Shares of Eli Lilly plunged after the drug maker reported less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a blockbuster. The pill helped people lose up to about 12% of their body weight after more than a year of treatment.

Eli Lilly weight loss pill shows promise

CBS News on MSN · 15h

Eli Lilly weight loss pill shows promise in latest clinical trial

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Reuters on MSN · 23h

Lilly pill cuts body weight by 12.4% in trial, lagging Novo's Wegovy injection

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's injectable obesity treatment Wegovy,

Yahoo Finance · 1m

Eli Lilly’s Miracle Weight Loss Pill May Not Be Miraculous Enough

Lilly's second-quarter results reported Thursday were still more than fine: $15.5 billion in revenue beat Wall Street estimates.

2hon MSN

Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?

The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...

17h

S&P 500 eases with Eli Lilly; Nasdaq manages record closing high

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

20hon MSN

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

13h

Stocks to Watch Recap: Eli Lilly, Firefly, DoorDash, TSMC

The iPhone maker's shares [rallied for a second day]( ...

FingerLakes1.com3h

Eli Lilly stock drops after obesity drug trial disappoints: What now?

Eli Lilly stock falls 14% after new obesity drug underwhelms in clinical trial. Analysts maintain Buy rating, citing strong ...

15hon MSN

These Stocks Are Moving the Most Today: Eli Lilly, Fortinet, AppLovin, Sunrun, Airbnb, Duolingo, and More

Fortinet, AppLovin, Airbnb, Duolingo and more stock were making big moves Thursday after the companies reported quarterly ...

17hon MSN

Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman

Complaints pour in over Army Corps’ Los Angeles fire cleanup efforts Helicopter crashes into barge on Mississippi River near ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results